Saito H - Search Results

1

[Prospective observational study of clinical course after stopping inhaled corticosteroids in child asthma].

Akasawa A, Suda T, Akashi M, Narita M, Ohya Y, Manki A, Watanabe H, Kumaki M, Matsumoto K, Saito H. Akasawa A, et al. Among authors: saito h. Arerugi. 2009 Oct;58(10):1407-17. Arerugi. 2009. PMID: 19901510 Japanese.

2

Factors associated with steroid phobia in caregivers of children with atopic dermatitis.

Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, Ohya Y, Saito H, Matsumoto K. Kojima R, et al. Among authors: saito h. Pediatr Dermatol. 2013 Jan-Feb;30(1):29-35. doi: 10.1111/j.1525-1470.2012.01808.x. Epub 2012 Jul 2. Pediatr Dermatol. 2013. PMID: 22747965

3

Eczematous sensitization, a novel pathway for allergic sensitization, can occur in an early stage of eczema.

Matsumoto K, Saito H. Matsumoto K, et al. Among authors: saito h. J Allergy Clin Immunol. 2014 Oct;134(4):865-6. doi: 10.1016/j.jaci.2014.08.006. J Allergy Clin Immunol. 2014. PMID: 25282567 No abstract available.

4

Childhood asthma control in Japan: A nationwide, cross-sectional, web-based survey.

Yoshida K, Sasaki M, Adachi Y, Itazawa T, Odajima H, Saito H, Akasawa A. Yoshida K, et al. Among authors: saito h. Asian Pac J Allergy Immunol. 2018 Mar;36(1):16-21. doi: 10.12932/AP0882. Asian Pac J Allergy Immunol. 2018. PMID: 28577524 Free article.

5

Influence of antibiotic use in early childhood on asthma and allergic diseases at age 5.

Yamamoto-Hanada K, Yang L, Narita M, Saito H, Ohya Y. Yamamoto-Hanada K, et al. Among authors: saito h. Ann Allergy Asthma Immunol. 2017 Jul;119(1):54-58. doi: 10.1016/j.anai.2017.05.013. Ann Allergy Asthma Immunol. 2017. PMID: 28668240 Free article.

6

Does asthma affect morbidity or severity of COVID-19?

Matsumoto K, Saito H. Matsumoto K, et al. Among authors: saito h. J Allergy Clin Immunol. 2020 Jul;146(1):55-57. doi: 10.1016/j.jaci.2020.05.017. Epub 2020 May 26. J Allergy Clin Immunol. 2020. PMID: 32470485 Free PMC article. No abstract available.

7

Immune checkpoint molecules on ILC2s as potential therapeutic targets for allergic diseases.

Morita H, Saito H, Matsumoto K. Morita H, et al. Among authors: saito h. J Allergy Clin Immunol. 2022 Jan;149(1):60-62. doi: 10.1016/j.jaci.2021.10.021. Epub 2021 Oct 27. J Allergy Clin Immunol. 2022. PMID: 34718042 No abstract available.

8

Biologics for allergic and immunologic diseases.

Morita H, Matsumoto K, Saito H. Morita H, et al. Among authors: saito h. J Allergy Clin Immunol. 2022 Oct;150(4):766-777. doi: 10.1016/j.jaci.2022.08.009. Epub 2022 Sep 2. J Allergy Clin Immunol. 2022. PMID: 36058723 Review.

9

[Immediate adverse reactions after administration of the influenza vaccine to patients with positive CAP-RAST to egg white].

Kawahara H, Morisawa Y, Katunuma T, Ohya Y, Saito H, Akasawa A. Kawahara H, et al. Among authors: saito h. Arerugi. 2002 Jul;51(7):559-64. Arerugi. 2002. PMID: 12201169 Japanese.

10

Total serum IgE level influences oral food challenge tests for IgE-mediated food allergies.

Horimukai K, Hayashi K, Tsumura Y, Nomura I, Narita M, Ohya Y, Saito H, Matsumoto K. Horimukai K, et al. Among authors: saito h. Allergy. 2015 Mar;70(3):334-7. doi: 10.1111/all.12562. Epub 2014 Dec 31. Allergy. 2015. PMID: 25495854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,622 results

Search Page

Filters